EXPLOITATION OF AN ANIMAL MODEL FOR PRIMARY BILIARY CIRRHOSIS AND ELUCIDATION OF ITS PATHOGENESIS

原发性胆汁性肝硬化动物模型的开发及其发病机制的阐明

基本信息

  • 批准号:
    02670306
  • 负责人:
  • 金额:
    $ 1.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1990
  • 资助国家:
    日本
  • 起止时间:
    1990 至 1992
  • 项目状态:
    已结题

项目摘要

In order to elucidate the pathogenesis of primary biliary cirrhosis (PBC), an animal model for PBC was prepared and analyzed morphologically and immunologically. Neonatally thymectomized (NTx) mice were immunized with various biliary antigens from the porcine liver. Bile duct lesions appeared only in mice immunized with bile duct antigens. The lesions were accompanied by dense infiltration of mononuclear cells with degeneration of biliary epithelial cells. Mononuclear cells were composed of lymphocytes, plasma cells and macrophages. Both CD4+ AND CD8+ lymphocytes were observed around the bile duct and CD4+ lymphocytes were predominant. Both MHC class I and class II antigens were demonstrated on bile duct epithelial cells. Serologically, anti-mitochondrial antibody was present and was revealed to be the antibody to pyruvate dehydrogenase as in human PBC. Furthermore, several antibodies to immunized bile duct antigens were demonstrated in the serum. These results suggest that the pathological and immunological findings of the present model resembles human PBC and can be used as an animal model for PBC. Further studies are needed to evaluate the animal model.
为探讨原发性胆汁性肝硬化(PBC)的发病机制,制备了PBC动物模型,并进行了形态学和免疫学分析。用来自猪肝的各种胆汁抗原免疫新生胸腺切除(NTx)小鼠。胆管病变只出现在胆管抗原免疫的小鼠。病变伴有单核细胞密集浸润及胆管上皮细胞变性。单核细胞由淋巴细胞、浆细胞和巨噬细胞组成。胆管周围可见CD4+和CD8+淋巴细胞,以CD4+淋巴细胞为主。MHC I类和II类抗原均在胆管上皮细胞上表达。血清学上,存在抗线粒体抗体,并显示为丙酮酸脱氢酶抗体,与人PBC相同。此外,在血清中显示了几种针对免疫胆管抗原的抗体。这些结果表明,本模型的病理和免疫学表现类似于人PBC,可以用作PBC的动物模型。需要进一步的研究来评估动物模型。

项目成果

期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamamoto K, et al: "Ultrastructural observation of bile duct lesions in an experimental model of primary biliary cirrhosis." J Clin Electron Microscopy. 24. 620-621 (1991)
Yamamoto K 等人:“原发性胆汁性肝硬化实验模型中胆管病变的超微结构观察。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamamoto K,et al.: "Ultrastructural observation of bile duct lesions in an experimental model of primary leiliary cirrhosis." J.Clin Electron Microscopy. 24. 620-621 (1991)
Yamamoto K 等人:“原发性杂状肝硬化实验模型中胆管病变的超微结构观察。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
YAMAMOTO K,et al: "Ultrastructural observation of lrile duct lesions in an experimental model of primary biliary cirshosis" J.Clin Electron Microscopy. 24. 620-621 (1991)
YAMAMOTO K 等人:“原发性胆汁性肝病实验模型中输卵管病变的超微结构观察”J.Clin 电子显微镜。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kobashi H, et al: "An experimental animal model for primary biliary cirrhosis using neonatally thymectomized mice. (in Japanese)" Kanzo. 32. 965 (1991)
Kobashi H 等人:“使用新生胸腺切除小鼠建立原发性胆汁性肝硬化实验动物模型。(日语)”Kanzo。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
小橋 春彦他: "新生期胸腺摘出マウスを用いた原発性胆汁性肝硬変(PBC)の動物実験モデル作成の試み" 肝臓. 32. 965 (1991)
Haruhiko Kobashi 等人:“尝试使用新生胸腺切除小鼠创建原发性胆汁性肝硬化 (PBC) 动物实验模型”Liver. 32. 965 (1991)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMAMOTO Kazuhide其他文献

YAMAMOTO Kazuhide的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMAMOTO Kazuhide', 18)}}的其他基金

Establishment of the cell therapy for liver failure using hepatocytes derived from induced pluripotent stem cells
利用诱导多能干细胞来源的肝细胞建立治疗肝衰竭的细胞疗法
  • 批准号:
    23590977
  • 财政年份:
    2011
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proposal of syntactic piece : its idea and application to statistical natural language processing tasks
句法片段的提议:其思想及其在统计自然语言处理任务中的应用
  • 批准号:
    21500133
  • 财政年份:
    2009
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene expression profiling of biliary epithelial cells in primary biliary cirrhosis : laser microdissection and microarray analysis
原发性胆汁性肝硬化胆管上皮细胞的基因表达谱:激光显微切割和微阵列分析
  • 批准号:
    12470122
  • 财政年份:
    2000
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of cytokine network in primary biliary cirrhosis
原发性胆汁性肝硬化细胞因子网络分析
  • 批准号:
    08670593
  • 财政年份:
    1996
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of T cell receptor repertoire in primary biliary cirrhosis
原发性胆汁性肝硬化T细胞受体库分析
  • 批准号:
    05670477
  • 财政年份:
    1993
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Galectin-3 in Primary biliary Cirrhosis
Galectin-3 在原发性胆汁性肝硬化中的作用
  • 批准号:
    8954302
  • 财政年份:
    2015
  • 资助金额:
    $ 1.54万
  • 项目类别:
Galectin-3 in Primary biliary Cirrhosis
Galectin-3 在原发性胆汁性肝硬化中的作用
  • 批准号:
    9070672
  • 财政年份:
    2015
  • 资助金额:
    $ 1.54万
  • 项目类别:
Translational studies to test potential therapies for patients with primary biliary cirrhosis
测试原发性胆汁性肝硬化患者潜在疗法的转化研究
  • 批准号:
    304870
  • 财政年份:
    2014
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Operating Grants
Functional analysis of transcription factor Nrf2 and production of new therapy in primary biliary cirrhosis
转录因子Nrf2的功能分析及原发性胆汁性肝硬化新疗法的产生
  • 批准号:
    26860499
  • 财政年份:
    2014
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Mechanism of hepatic fibrosis and cytokines in primary biliary cirrhosis (PBC).
原发性胆汁性肝硬化(PBC)中肝纤维化和细胞因子的机制。
  • 批准号:
    25461015
  • 财政年份:
    2013
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of an antigen-specific nanomedicine for the treatment of primary biliary cirrhosis, a severe autoimmune disease of the liver
开发用于治疗原发性胆汁性肝硬化(一种严重的自身免疫性肝脏疾病)的抗原特异性纳米药物
  • 批准号:
    297029
  • 财政年份:
    2013
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Fellowship Programs
Stratified Medicine in Primary Biliary Cirrhosis (PBC): Understanding Disease Mechanisms and Targeting Therapies (UK-PBC)
原发性胆汁性肝硬化 (PBC) 的分层医学:了解疾病机制和靶向治疗 (UK-PBC)
  • 批准号:
    MR/L001489/1
  • 财政年份:
    2013
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Research Grant
Genome and virulence factor analysis of streptococci affected to chronic inflammatory diseases including primary biliary cirrhosis
原发性胆汁性肝硬化等慢性炎症性疾病链球菌基因组及毒力因子分析
  • 批准号:
    24590536
  • 财政年份:
    2012
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel approach to primary biliary cirrhosis putting focus on deregulated autophagy
原发性胆汁性肝硬化的新方法重点关注自噬失调
  • 批准号:
    24590409
  • 财政年份:
    2012
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Regulatory B cell Distribution and Function in Primary Biliary Cirrhosis (Cholangitis) Model Mice and Optimization of B cell Targeted Therapy
原发性胆汁性肝硬化(胆管炎)模型小鼠调节性B细胞分布及功能分析及B细胞靶向治疗优化
  • 批准号:
    24590952
  • 财政年份:
    2012
  • 资助金额:
    $ 1.54万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了